The role of abhydrolase domain-containing 15 (Abhd15) in lipid metabolism in adipocytes

Wenmin XIA, Ariane Pessentheiner, Evelyn Walenta , Thomas Rülicke, Gerald Rechberger, Hubert Hackl, Juliane Gertrude Bogner-Strauß

Research output: Contribution to conferencePosterResearchpeer-review

Abstract

Background and Aims: Deregulated lipid metabolism is closely related to many metabolic diseases. Abhd15 expression is strongly increased during adipocyte differentiation and regulated by nutritional changes. Abhd15 associates with phosphodiesterase 3B (PDE3B) and they have the same tissue and subcellular distribution. In white adipose tissue (WAT), PDE3B controls intracellular cyclic AMP level and is thus required for the inhibition of lipolysis by insulin. We hypothesize that Abhd15 affects lipolysis through interaction with PDE3B.

Results: To study the impact of Abhd15 on lipolysis in vitro, we generated 3T3-L1 cells stably overexpressing Abhd15 (Abhd15 o/e) and differentiated them into adipocytes. Our results show that Abhd15 o/e strongly increased basal glycerol release and phosphorylation of HSL at Ser660 in adipocytes. In Cos7 cells, we confirmed the interaction of Abhd15 with PDE3B and we could further show it in adipocytes. Additionally, increasing protein expression of Abhd15 reduced PDE3B protein expression in Cos7 cells and adipocytes. Concomitantly, PDE3B activity was inhibited by membrane fraction lysates from Abhd15 o/e Cos7 cells. We also investigated Abhd15 protein expression at different nutritional states in WAT. While fasting decreased Abhd15 expression, refeeding strongly increased it. PDE3B has the same expression pattern as Abhd15. Also, in WAT of Abhd15-ko mice, PDE3B mRNA and protein expression are strongly reduced in fasted and refed. Accordingly, our in vivo results show that Abhd15-ko mice do not shut down lipolysis after insulin injection.

Conclusion: Our data show that Abhd15 impacts PDE3B expression and activity, thereby affecting lipolysis in vitro and in vivo. In summary, we present Abhd15 as a novel regulator of PDE3B and suggest that Abhd15 plays an important role in insulin signaling, such as lipolysis and adaption to nutritional changes.
Original languageEnglish
Publication statusPublished - 12 Sep 2016
EventLipoprotein Metabolism 2016 Gordon Research Conference - Waterville Valley in Waterville Valley NH United States, New Hampshire, United States
Duration: 12 Jun 201617 Jun 2016
https://www.grc.org/programs.aspx?id=12711

Conference

ConferenceLipoprotein Metabolism 2016 Gordon Research Conference
CountryUnited States
CityNew Hampshire
Period12/06/1617/06/16
Internet address

Fingerprint

Type 3 Cyclic Nucleotide Phosphodiesterases
Lipid Metabolism
Adipocytes
Lipolysis
White Adipose Tissue
Insulin
Proteins
3T3-L1 Cells
Metabolic Diseases
Tissue Distribution
Cell Communication
Cyclic AMP
Glycerol
Fasting
Phosphorylation

Cite this

XIA, W., Pessentheiner, A., Walenta , E., Rülicke, T., Rechberger, G., Hackl, H., & Bogner-Strauß, J. G. (2016). The role of abhydrolase domain-containing 15 (Abhd15) in lipid metabolism in adipocytes. Poster session presented at Lipoprotein Metabolism 2016 Gordon Research Conference, New Hampshire, United States.

The role of abhydrolase domain-containing 15 (Abhd15) in lipid metabolism in adipocytes. / XIA, Wenmin; Pessentheiner, Ariane; Walenta , Evelyn; Rülicke, Thomas; Rechberger, Gerald; Hackl, Hubert ; Bogner-Strauß, Juliane Gertrude.

2016. Poster session presented at Lipoprotein Metabolism 2016 Gordon Research Conference, New Hampshire, United States.

Research output: Contribution to conferencePosterResearchpeer-review

XIA, W, Pessentheiner, A, Walenta , E, Rülicke, T, Rechberger, G, Hackl, H & Bogner-Strauß, JG 2016, 'The role of abhydrolase domain-containing 15 (Abhd15) in lipid metabolism in adipocytes' Lipoprotein Metabolism 2016 Gordon Research Conference, New Hampshire, United States, 12/06/16 - 17/06/16, .
XIA W, Pessentheiner A, Walenta E, Rülicke T, Rechberger G, Hackl H et al. The role of abhydrolase domain-containing 15 (Abhd15) in lipid metabolism in adipocytes. 2016. Poster session presented at Lipoprotein Metabolism 2016 Gordon Research Conference, New Hampshire, United States.
XIA, Wenmin ; Pessentheiner, Ariane ; Walenta , Evelyn ; Rülicke, Thomas ; Rechberger, Gerald ; Hackl, Hubert ; Bogner-Strauß, Juliane Gertrude. / The role of abhydrolase domain-containing 15 (Abhd15) in lipid metabolism in adipocytes. Poster session presented at Lipoprotein Metabolism 2016 Gordon Research Conference, New Hampshire, United States.
@conference{a1ea5bb17cbf48929a5949013c2358f7,
title = "The role of abhydrolase domain-containing 15 (Abhd15) in lipid metabolism in adipocytes",
abstract = "Background and Aims: Deregulated lipid metabolism is closely related to many metabolic diseases. Abhd15 expression is strongly increased during adipocyte differentiation and regulated by nutritional changes. Abhd15 associates with phosphodiesterase 3B (PDE3B) and they have the same tissue and subcellular distribution. In white adipose tissue (WAT), PDE3B controls intracellular cyclic AMP level and is thus required for the inhibition of lipolysis by insulin. We hypothesize that Abhd15 affects lipolysis through interaction with PDE3B.Results: To study the impact of Abhd15 on lipolysis in vitro, we generated 3T3-L1 cells stably overexpressing Abhd15 (Abhd15 o/e) and differentiated them into adipocytes. Our results show that Abhd15 o/e strongly increased basal glycerol release and phosphorylation of HSL at Ser660 in adipocytes. In Cos7 cells, we confirmed the interaction of Abhd15 with PDE3B and we could further show it in adipocytes. Additionally, increasing protein expression of Abhd15 reduced PDE3B protein expression in Cos7 cells and adipocytes. Concomitantly, PDE3B activity was inhibited by membrane fraction lysates from Abhd15 o/e Cos7 cells. We also investigated Abhd15 protein expression at different nutritional states in WAT. While fasting decreased Abhd15 expression, refeeding strongly increased it. PDE3B has the same expression pattern as Abhd15. Also, in WAT of Abhd15-ko mice, PDE3B mRNA and protein expression are strongly reduced in fasted and refed. Accordingly, our in vivo results show that Abhd15-ko mice do not shut down lipolysis after insulin injection.Conclusion: Our data show that Abhd15 impacts PDE3B expression and activity, thereby affecting lipolysis in vitro and in vivo. In summary, we present Abhd15 as a novel regulator of PDE3B and suggest that Abhd15 plays an important role in insulin signaling, such as lipolysis and adaption to nutritional changes.",
author = "Wenmin XIA and Ariane Pessentheiner and Evelyn Walenta and Thomas R{\"u}licke and Gerald Rechberger and Hubert Hackl and Bogner-Strau{\ss}, {Juliane Gertrude}",
year = "2016",
month = "9",
day = "12",
language = "English",
note = "Lipoprotein Metabolism 2016 Gordon Research Conference ; Conference date: 12-06-2016 Through 17-06-2016",
url = "https://www.grc.org/programs.aspx?id=12711",

}

TY - CONF

T1 - The role of abhydrolase domain-containing 15 (Abhd15) in lipid metabolism in adipocytes

AU - XIA, Wenmin

AU - Pessentheiner, Ariane

AU - Walenta , Evelyn

AU - Rülicke, Thomas

AU - Rechberger, Gerald

AU - Hackl, Hubert

AU - Bogner-Strauß, Juliane Gertrude

PY - 2016/9/12

Y1 - 2016/9/12

N2 - Background and Aims: Deregulated lipid metabolism is closely related to many metabolic diseases. Abhd15 expression is strongly increased during adipocyte differentiation and regulated by nutritional changes. Abhd15 associates with phosphodiesterase 3B (PDE3B) and they have the same tissue and subcellular distribution. In white adipose tissue (WAT), PDE3B controls intracellular cyclic AMP level and is thus required for the inhibition of lipolysis by insulin. We hypothesize that Abhd15 affects lipolysis through interaction with PDE3B.Results: To study the impact of Abhd15 on lipolysis in vitro, we generated 3T3-L1 cells stably overexpressing Abhd15 (Abhd15 o/e) and differentiated them into adipocytes. Our results show that Abhd15 o/e strongly increased basal glycerol release and phosphorylation of HSL at Ser660 in adipocytes. In Cos7 cells, we confirmed the interaction of Abhd15 with PDE3B and we could further show it in adipocytes. Additionally, increasing protein expression of Abhd15 reduced PDE3B protein expression in Cos7 cells and adipocytes. Concomitantly, PDE3B activity was inhibited by membrane fraction lysates from Abhd15 o/e Cos7 cells. We also investigated Abhd15 protein expression at different nutritional states in WAT. While fasting decreased Abhd15 expression, refeeding strongly increased it. PDE3B has the same expression pattern as Abhd15. Also, in WAT of Abhd15-ko mice, PDE3B mRNA and protein expression are strongly reduced in fasted and refed. Accordingly, our in vivo results show that Abhd15-ko mice do not shut down lipolysis after insulin injection.Conclusion: Our data show that Abhd15 impacts PDE3B expression and activity, thereby affecting lipolysis in vitro and in vivo. In summary, we present Abhd15 as a novel regulator of PDE3B and suggest that Abhd15 plays an important role in insulin signaling, such as lipolysis and adaption to nutritional changes.

AB - Background and Aims: Deregulated lipid metabolism is closely related to many metabolic diseases. Abhd15 expression is strongly increased during adipocyte differentiation and regulated by nutritional changes. Abhd15 associates with phosphodiesterase 3B (PDE3B) and they have the same tissue and subcellular distribution. In white adipose tissue (WAT), PDE3B controls intracellular cyclic AMP level and is thus required for the inhibition of lipolysis by insulin. We hypothesize that Abhd15 affects lipolysis through interaction with PDE3B.Results: To study the impact of Abhd15 on lipolysis in vitro, we generated 3T3-L1 cells stably overexpressing Abhd15 (Abhd15 o/e) and differentiated them into adipocytes. Our results show that Abhd15 o/e strongly increased basal glycerol release and phosphorylation of HSL at Ser660 in adipocytes. In Cos7 cells, we confirmed the interaction of Abhd15 with PDE3B and we could further show it in adipocytes. Additionally, increasing protein expression of Abhd15 reduced PDE3B protein expression in Cos7 cells and adipocytes. Concomitantly, PDE3B activity was inhibited by membrane fraction lysates from Abhd15 o/e Cos7 cells. We also investigated Abhd15 protein expression at different nutritional states in WAT. While fasting decreased Abhd15 expression, refeeding strongly increased it. PDE3B has the same expression pattern as Abhd15. Also, in WAT of Abhd15-ko mice, PDE3B mRNA and protein expression are strongly reduced in fasted and refed. Accordingly, our in vivo results show that Abhd15-ko mice do not shut down lipolysis after insulin injection.Conclusion: Our data show that Abhd15 impacts PDE3B expression and activity, thereby affecting lipolysis in vitro and in vivo. In summary, we present Abhd15 as a novel regulator of PDE3B and suggest that Abhd15 plays an important role in insulin signaling, such as lipolysis and adaption to nutritional changes.

M3 - Poster

ER -